These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3309759)

  • 21. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.
    Kunze E; Schulz H; Adamek M; Gabius HJ
    J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
    Gardin NE
    Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of Echinacea angustifolia on non-specific cellular immunity in the mouse].
    Schumacher A; Friedberg KD
    Arzneimittelforschung; 1991 Feb; 41(2):141-7. PubMed ID: 2043176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of mistletoe (Viscum album L.) extracts on cultured tumor cells.
    Ribéreau-Gayon G; Jung ML; Baudino S; Sallé G; Beck JP
    Experientia; 1986 Jun; 42(6):594-9. PubMed ID: 3013672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study on the effects of aqueous extracts of viscum album (mistletoe) from three host plants on hematological parameters in albino rats.
    Ladokun O; Ojezele M; Arojojoye O
    Afr Health Sci; 2015 Jun; 15(2):606-12. PubMed ID: 26124810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Arthrosis therapy with Viscum album, plenosol].
    HIENERT G; KISSLER F
    Wien Med Wochenschr; 1952 Nov; 102(46):931-2. PubMed ID: 13029505
    [No Abstract]   [Full Text] [Related]  

  • 27. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
    Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
    Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mistletoe in the treatment of cancer].
    Bruseth S; Enge A
    Tidsskr Nor Laegeforen; 1993 Mar; 113(9):1058-60. PubMed ID: 8493669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of Viscum album preparations on the natural killer cell-mediated cytotoxicity of peripheral blood.
    Hülsen H; Kron R; Mechelke F
    Naturwissenschaften; 1989 Nov; 76(11):530-1. PubMed ID: 2615845
    [No Abstract]   [Full Text] [Related]  

  • 30. [Viscum album in the treatment of neoplasms].
    Leroi R
    Ther Ggw; 1971 Oct; 110(10):1496-504. PubMed ID: 4946592
    [No Abstract]   [Full Text] [Related]  

  • 31. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaphylaxis to viscotoxins of mistletoe (Viscum album) extracts.
    Bauer C; Oppel T; Ruëff F; Przybilla B
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):86-9. PubMed ID: 15702822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro.
    Weissenstein U; Kunz M; Urech K; Regueiro U; Baumgartner S
    BMC Complement Altern Med; 2016 Aug; 16():271. PubMed ID: 27491866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of the immune response in outpatients with hepatocellular carcinomas by low doses of cyclophosphamide (LDCY), echinacea purpurea extracts (Echinacin) and thymostimulin.
    Lersch C; Zeuner M; Bauer A; Siebenrock K; Hart R; Wagner F; Fink U; Dancygier H; Classen M
    Arch Geschwulstforsch; 1990; 60(5):379-83. PubMed ID: 2173516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals.
    Gorter RW; van Wely M; Reif M; Stoss M
    Altern Ther Health Med; 1999 Nov; 5(6):37-44, 47-8. PubMed ID: 10550904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of antitumour immunity by intrapleural instillation of a Viscum album L. extract.
    Stumpf C; Büssing A
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S23-6. PubMed ID: 9179363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Isolation and characterization of mistletoe extracts (Viscum album L.). II. Effect of agglutinating and cytotoxic fractions on mouse ascites tumor cells].
    Luther P; Franz H; Haustein B; Bergmann KC
    Acta Biol Med Ger; 1977; 36(1):119-25. PubMed ID: 560094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease of activated lymphocytes four and nine hours after a subcutaneous injection of a Viscum album L. extract in healthy volunteers.
    Stoss M; Peter E; Gorter RW
    Nat Immun; 1998; 16(5-6):185-97. PubMed ID: 11061587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins.
    Büssing A; Schietzel M
    Anticancer Res; 1999; 19(1A):23-8. PubMed ID: 10226520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of IL-12 and the production of IFN-gamma, IL-2 and IL-4 by peripheral blood mononuclear cells (PBMC) in cancer patients treated with Viscum album extract.
    Kovacs E
    Biomed Pharmacother; 2000 Jul; 54(6):305-10. PubMed ID: 10989963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.